More than 11,000 bottles of a popular blood pressure medication distributed nationwide has been recalled, according to the U.S. Food and Drug Administration.
The recall involves bottles of Spironolactone Tablets, USP, 25 mg, 100-count — manufactured by Frontida BioPharm, Inc., and distributed by Sun Pharmaceutical Industries, Inc.
The medication could contain the presence of foreign substance, identified as aluminum.
The medication under recall includes bottles with a lot number of P3314 and an expiration date of Nov. 30, 2026.
The bottles were distributed nationwide.
The recall was initiated on Aug. 5, and was classified to a Class II risk level on Aug. 8.
A Class II recall is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
The recall remains ongoing, according to the U.S. Food and Drug Administration report.
If you purchase a product or register for an account through a link on our site, we may receive compensation. By using this site, you consent to our User Agreement and agree that your clicks, interactions, and personal information may be collected, recorded, and/or stored by us and social media and other third-party partners in accordance with our Privacy Policy.
Source link
